Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Head of the 3rd Med. Dept. of Cardiology and Internal Intensive Care Medicine
Prof Kurt Huber is Head of the 3rd Med. Dept. with Cardiology and Internal Intensive Care Medicine at the Clinic Ottakring, Vienna. Prof Huber is an interventional cardiologist with over 35 years of experience. His main research interest covers basic research (mechanisms of thrombus formation and dissolution) as well as clinical research (acute coronary syndromes, organization of STEMI… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022. Trials covered in detail include: 00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients… View more
Job title: Interventional Cardiologist
Personal History Dr Fizzah Choudry is a Consultant in Interventional Cardiology at St Bartholomew's Hospital, London, UK. Academic History Dr Choudry holds a PhD in medicine. She trained as a doctor in Welwyn Garden City, Hertfordshire, UK. Career Overview In addition to Barts Heart Centre’s Department of Cardiology, she is affiliated with the Department of Hematology at… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice. Trials covered in detail include: 00:29: PACMAN AMI:… View more